Ingestible Wirelessly Powered Electronics Devices

April 30, 2017 Scipreneur Private Limited 0

Ingestible Wirelessly Powered Electronics Devices By: Anne Trafton | MIT News Office April 30, 2017 Researchers at MIT, Brigham and Women’s Hospital, and the Charles Stark Draper Laboratory have devised a way to wirelessly power small electronic devices that can linger in the digestive tract indefinitely after being swallowed. Such [..]

Stronger Polymers: By A Simple & New Method

April 24, 2017 Scipreneur Private Limited 0

Stronger Polymers: By A Simple & New Method  Source: Anne Trafton | MIT News Office April 24, 2017 Plastic, rubber, and many other useful materials are made of polymers — long chains arranged in a cross-linked network. At the molecular level, these polymer networks contain structural flaws that weaken them. [..]

Novartis CAR-T Cell Therapy (CTL019) Receives FDA Breakthrough Therapy Designation

April 22, 2017 Scipreneur Private Limited 0

Novartis CAR-T Cell Therapy (CTL019) Receives FDA Breakthrough Therapy Designation  Source: Novartis NEWS April 22, 2017 R/r DLBCL, an aggressive cancer with limited options, is the second indication for CTL019 to receive Breakthrough Therapy designation Advances in CTL019 result from collaboration with the University of Pennsylvania; regulatory submissions for r/r [..]

Novel Lens For Super-Resolution Imaging

April 21, 2017 Scipreneur Private Limited 0

Novel Lens For Super-Resolution Imaging Source: NUS News April 21, 2017 The optical microscope is a critical equipment for scientific research and failure inspection in high precision industries. However, for centuries, the imaging resolution of microscopes is fundamentally limited by the diffraction limit of light. Existing efforts to break this [..]

FDA Approved Neurocrine’s INGREZZA TM As First and Only Treatment for Tardive Dyskinesia (TD)

April 19, 2017 Scipreneur Private Limited 0

FDA Approved Neurocrine’s INGREZZATM As First and Only Treatment for Tardive Dyskinesia (TD) April 19, 2017 Source: Neurocrine Biosciences, Inc NEWS Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced that the U.S. Food and Drug Administration (FDA) has approved INGREZZATM (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD). INGREZZA, a novel, selective [..]

Breakthrough In Gene-Editing

April 17, 2017 Scipreneur Private Limited 0

Breakthrough In Gene-Editing  Source: SNU Media April 17, 2017 Professor Kim Jin-Soo and training researcher Kim Daesik, both of the Department of Chemistry, were part of a research team at the Center for Genomic Engineering, within the Institute for Basic Science (IBS), that proved that a newly developed gene editing [..]